Innate Pharma (IPHA) Stock Chart & Stock Price History $2.06 -0.14 (-6.14%) As of 02:28 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Innate Pharma Stock Price Performance The Innate Pharma (IPHA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 5.14%, with a year-to-date return of 16.00%. In the past month, the stock has increased 34.44%, reflecting recent market activity. As of the latest close, Innate Pharma traded at $2.20 with a market cap of $206.62 million and volume of 30,053 shares. Five years ago, the stock traded at $4.03, representing a 49.63% decrease over that period. At the time, it had a market cap of $318.33 million and a volume of 1,554 shares. Receive IPHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+0.50%1 Month Performance+34.44%3 Month Performance+25.31%Year-To-Date Performance+16.00%1 Year Performance-5.14%5 Year Performance-49.63% IPHA Stock Chart for Thursday, May, 21, 2026 IPHA Chart by TradingView Innate Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/20/2026$2.03$2.20+8.37%$2.30$2.0830,053 shs$206.62 million05/19/2026$2.25$2.03-9.78%$2.30$1.9978,568 shs$190.66 million05/18/2026$2.02$2.25+11.39%$2.32$2.17114,352 shs$211.32 million05/15/2026$2.17$2.02-6.91%$2.16$1.93209,564 shs$189.72 million05/14/2026$1.32$2.17+64.39%$2.62$1.562.37 million shs$203.81 million05/13/2026$1.36$1.32-2.94%$1.41$1.329,264 shs$123.97 million05/12/2026$1.42$1.36-4.23%$1.40$1.343,219 shs$127.73 million05/11/2026$1.41$1.42+0.71%$1.48$1.425,227 shs$133.37 million05/08/2026$1.37$1.41+2.92%$1.49$1.406,801 shs$128.67 million05/07/2026$1.51$1.37-9.27%$1.48$1.3729,097 shs$128.67 million Get the Latest News and Ratings for IPHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. 05/06/2026$1.40$1.51+7.86%$1.56$1.4815,986 shs$141.82 million05/05/2026N/A$1.40$1.54$1.4025,808 shs$131.49 million04/30/2026$1.48$1.44-2.70%$1.47$1.4243,703 shs$135.11 million04/29/2026$1.40$1.48+5.71%$1.49$1.4567,428 shs$138.86 million04/28/2026$1.40$1.40$1.43$1.3911,989 shs$131.35 million04/27/2026$1.41$1.40-0.71%$1.40$1.369,926 shs$131.35 million04/24/2026$1.37$1.41+2.92%$1.42$1.3526,674 shs$132.29 million04/23/2026$1.43$1.37-4.20%$1.45$1.374,539 shs$128.54 million04/22/2026$1.51$1.43-5.30%$1.47$1.3925,444 shs$134.16 million04/21/2026$1.59$1.51-5.03%$1.56$1.517,893 shs$141.67 million04/20/2026$1.66$1.59-4.22%$1.65$1.5713,777 shs$149.17 million Related Companies AURA Stock Price Chart RGNX Stock Price Chart TECX Stock Price Chart ANL Stock Price Chart CTNM Stock Price Chart PRTA Stock Price Chart OCGN Stock Price Chart UPB Stock Price Chart KMDA Stock Price Chart NGNE Stock Price Chart Receive IPHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IPHA) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredElon’s AI supercomputer just went live. Here’s my #1 stock.Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
